K. E. Potts

Genetic heterogeneity of the V3 region of the HIV‐1 envelope glycoprotein in Brazil

C. Luo, M. Kalish, O. Ferreira, 1993, AIDS.

Protease Inhibitors as Antiviral Agents

A. Patick, K. E. Potts, A. K. Patick, 1998, Clinical Microbiology Reviews.

Adenoviral gene transfer of nitric oxide synthase: high level expression in human vascular cells.

K. Channon, S. George, K. E. Potts, 1996, Cardiovascular Research.

V3 loops of HIV-1 specimens from pregnant women in Malawi uniformly lack a potential N-linked glycosylation site.

M. Kalish, G. Dallabetta, C. Ou, 1993, AIDS research and human retroviruses.

Estimate of the Frequency of Human Immunodeficiency Virus Type 1 Protease Inhibitor Resistance within Unselected Virus Populations In Vitro

S. Tucker, K. E. Potts, M. Smidt, 1998, Antimicrobial Agents and Chemotherapy.

HUMAN IMMUNODEFICIENCY VIRUS PROTEASE Since the identification of HIV as the causative agent of AIDS

A. Patick, K. E. Potts, 1998 .

Genetic diversity of human immunodeficiency virus type 1 strains in Kinshasa, Zaire.

M. Kalish, M. S. St. Louis, C. Ou, 1993, AIDS research and human retroviruses.

A mutation in human immunodeficiency virus type 1 protease at position 88, located outside the active site, confers resistance to the hydroxyethylurea inhibitor SC-55389A

D. Richman, W. Stallings, S. Tucker, 1997, Antimicrobial agents and chemotherapy.